Motif Neurotech announced that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation implant.
Houston-based Motif plans for its RESONATE early feasibility study to evaluate its Motif XCS wirelessly powered implant. Motif...
Motif Neurotech announced that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation implant.
Houston-based Motif plans for its RESONATE early feasibility...
SquareMind has raised $18 million for its Swan robotic skin imaging platform, including an investment from Fred Moll’s Sonder Capital.
The Paris-based startup said the...
BrioHealth announced that it received conditional FDA approval to conduct a clinical evaluation of its ventricular assist device (VAD) in pediatric patients.
Burlington, Massachusetts–based BrioHealth...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
Findings come from the OSPREY study, which London-based LivaNova...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Motif Neurotech announced that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation implant.
Houston-based Motif plans for its RESONATE early feasibility...
SquareMind has raised $18 million for its Swan robotic skin imaging platform, including an investment from Fred Moll’s Sonder Capital.
The Paris-based startup said the...
BrioHealth announced that it received conditional FDA approval to conduct a clinical evaluation of its ventricular assist device (VAD) in pediatric patients.
Burlington, Massachusetts–based BrioHealth...